Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Convatec Group Plc, headquartered in Great Britain, is a leading player in the medical, precision, and optical instruments industry. Founded in 1978, the company has established itself as a pioneer in advanced wound care, ostomy care, continence and critical care, and infusion devices. With a strong presence in Europe, North America, and Asia-Pacific, Convatec is committed to enhancing patient outcomes through innovative healthcare solutions.
The company’s core products, including advanced wound dressings and ostomy appliances, are distinguished by their quality and effectiveness, addressing the unique needs of patients and healthcare professionals alike. Convatec's dedication to research and development has positioned it as a trusted name in the industry, achieving significant milestones such as the launch of groundbreaking products that improve patient quality of life. With a robust market position, Convatec continues to drive advancements in medical technology, making a meaningful impact in the healthcare sector.
+43 vs industry average
Convatec’s score of 75 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has typical carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Convatec, a UK-headquartered company in the Medical, precision and optical instruments, watches and clocks industry, reported total global greenhouse gas emissions of approximately 295,296,000 kg CO2e in 2025. This includes 12,780,000 kg CO2e from Scope 1 emissions, 85,000 kg CO2e from market-based Scope 2 emissions, and 282,431,000 kg CO2e from Scope 3 emissions.
Looking back, Convatec's total emissions were approximately 247,413,000 kg CO2e in 2024, comprising 12,360,000 kg CO2e in Scope 1, 1,463,000 kg CO2e in market-based Scope 2, and 233,590,000 kg CO2e in Scope 3. In 2023, the company's total emissions were about 262,913,000 kg CO2e, with 14,632,000 kg CO2e from Scope 1, 1,510,000 kg CO2e from market-based Scope 2, and 246,771,000 kg CO2e from Scope 3.
Convatec has set an ambitious strategic climate commitment to achieve net zero emissions by 2045. The company also has Science Based Targets initiative (SBTi) approved near-term targets. These include a commitment to reduce absolute Scope 1 and 2 greenhouse gas emissions by 70% by 2030, using a 2021 base year. Additionally, Convatec aims to reduce Scope 3 greenhouse gas emissions from purchased goods and services, upstream transportation and distribution, and waste generated in operations by 52% per sold product by 2030, also against a 2021 baseline.
2030
70% reduction in Scope 2
Convatec commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2021 base year. Convatec also commits to reduce scope 3 G…
2030
70% reduction in Scope 1
Convatec commits to reduce absolute scope 1 and 2 GHG emissions 70% by 2030 from a 2021 base year. Convatec also commits to reduce scope 3 G…
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Convatec’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more